Humana (HUM) Projected to Post Earnings on Wednesday

Humana (NYSE:HUM) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect the company to announce earnings of ($4.01) per share and revenue of $32.0804 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 11, 2026 at 8:00 AM ET.

Humana Stock Performance

Shares of HUM opened at $189.64 on Tuesday. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. Humana has a 12-month low of $186.00 and a 12-month high of $315.35. The stock has a market cap of $22.81 billion, a P/E ratio of 17.77, a PEG ratio of 1.61 and a beta of 0.44. The company has a 50-day moving average of $250.49 and a two-hundred day moving average of $262.76.

Analyst Upgrades and Downgrades

HUM has been the topic of several analyst reports. Wells Fargo & Company cut Humana from an “overweight” rating to a “cautious” rating in a report on Wednesday, January 7th. Truist Financial reduced their target price on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Morgan Stanley restated an “underperform” rating on shares of Humana in a report on Thursday, December 18th. Robert W. Baird dropped their price objective on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. Finally, Jefferies Financial Group decreased their target price on shares of Humana from $313.00 to $310.00 and set a “buy” rating on the stock in a research report on Monday, January 26th. Eight equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $293.21.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Larson Financial Group LLC increased its holdings in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares during the last quarter. Fulcrum Asset Management LLP acquired a new stake in shares of Humana during the third quarter worth approximately $42,000. BOKF NA increased its stake in shares of Humana by 4,125.0% in the third quarter. BOKF NA now owns 169 shares of the insurance provider’s stock worth $44,000 after buying an additional 165 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in Humana by 40.3% in the second quarter. Geneos Wealth Management Inc. now owns 571 shares of the insurance provider’s stock valued at $140,000 after acquiring an additional 164 shares in the last quarter. Finally, Sunbelt Securities Inc. boosted its stake in Humana by 18.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 719 shares of the insurance provider’s stock valued at $187,000 after acquiring an additional 110 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.